DE69937060D1 - Immunogene zusammensetzungen und deren verwendungen - Google Patents

Immunogene zusammensetzungen und deren verwendungen

Info

Publication number
DE69937060D1
DE69937060D1 DE69937060T DE69937060T DE69937060D1 DE 69937060 D1 DE69937060 D1 DE 69937060D1 DE 69937060 T DE69937060 T DE 69937060T DE 69937060 T DE69937060 T DE 69937060T DE 69937060 D1 DE69937060 D1 DE 69937060D1
Authority
DE
Germany
Prior art keywords
immunogenic compositions
immunogenic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69937060T
Other languages
English (en)
Inventor
Louis Schofield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Application granted granted Critical
Publication of DE69937060D1 publication Critical patent/DE69937060D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69937060T 1998-09-14 1999-09-14 Immunogene zusammensetzungen und deren verwendungen Expired - Lifetime DE69937060D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP5893A AUPP589398A0 (en) 1998-09-14 1998-09-14 Immunogenic compositions and uses thereof
PCT/AU1999/000770 WO2000015254A1 (en) 1998-09-14 1999-09-14 Immunogenic compositions and uses thereof

Publications (1)

Publication Number Publication Date
DE69937060D1 true DE69937060D1 (de) 2007-10-18

Family

ID=3810114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69937060T Expired - Lifetime DE69937060D1 (de) 1998-09-14 1999-09-14 Immunogene zusammensetzungen und deren verwendungen

Country Status (5)

Country Link
US (3) US7575755B1 (de)
EP (1) EP1113815B1 (de)
AU (1) AUPP589398A0 (de)
DE (1) DE69937060D1 (de)
WO (1) WO2000015254A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808443A1 (de) * 2006-01-13 2007-07-18 Institut Pasteur Gereinigtes Polypeptid beinhaltend oder bestehend aus einem C-terminalen MSP1 Antigen von Plasmodium falciparum das eine Glycosylphosphatidylinositol-Gruppe (GPI) trägt
US8188213B2 (en) 1996-02-14 2012-05-29 Institut Pasteur Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI)
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
EP1171157B1 (de) * 1999-04-22 2006-08-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verwendung von glukose-6-phosphate-isomerase und dagegen gerichteten antikörpern zur diagnose und therapeutischen behandlung von arthritis, und test von zur behandlung der arthritis wirksamen verbindungen
US7033745B1 (en) 1999-04-22 2006-04-25 Institut National De La Sante Et De La Rescherche Medicale (Inserm) Use of gluclose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
ATE390434T1 (de) * 2000-05-12 2008-04-15 Rodaris Pharmaceuticals Ltd Inositolphosphoglycanderivate und ihre medizinische verwendung
HUE025624T2 (en) * 2002-07-26 2016-04-28 The Walter And Eliza Hall Inst Of Medical Res Immunogenic preparations and diagnostic and therapeutic use
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
WO2005120519A1 (en) * 2004-06-10 2005-12-22 The Walter And Eliza Hall Institute Of Medical Research Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors
WO2017075053A1 (en) * 2015-10-26 2017-05-04 Cour Pharmaceuticals Development Company Inc. Immune-modifying particles for the treatment of malaria

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9203039D0 (en) * 1992-02-13 1992-03-25 Univ London Treatment
DE4311580C1 (de) * 1993-04-12 1994-08-18 Werner Prof Dr Med Reutter Glycoproteine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
US6113917A (en) * 1995-04-25 2000-09-05 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
EP0850244B1 (de) * 1995-09-15 2002-07-31 Organon Teknika B.V. Toxoplasma gondii glykokonjugate
WO1997026911A1 (en) * 1996-01-29 1997-07-31 Georgetown University Malaria vaccine based upon the addition of a msa1 peptide
US7968689B2 (en) * 1997-03-07 2011-06-28 Human Genome Sciences, Inc. Antibodies to HSDEK49 polypeptides
US5968742A (en) * 1997-05-22 1999-10-19 Incyte Pharmaceuticals, Inc. Human GPI2 homolog
US20070014787A1 (en) * 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
AUPP589398A0 (en) * 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
AUPP675898A0 (en) * 1998-10-27 1998-11-19 Walter And Eliza Hall Institute Of Medical Research, The A method of activating t cells and agents useful for same
WO2004005532A2 (en) * 2002-07-10 2004-01-15 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
HUE025624T2 (en) * 2002-07-26 2016-04-28 The Walter And Eliza Hall Inst Of Medical Res Immunogenic preparations and diagnostic and therapeutic use
US7393534B2 (en) * 2003-07-15 2008-07-01 Barros Research Institute Compositions and methods for immunotherapy of cancer and infectious diseases
WO2005120519A1 (en) * 2004-06-10 2005-12-22 The Walter And Eliza Hall Institute Of Medical Research Glycosylphosphatidylinositol glycan signalling via integrins functioning as glycan specific receptors
US7928077B2 (en) * 2008-07-11 2011-04-19 Academia Sinica Alpha-galactosyl ceramide analogs and their use as immunotherapies

Also Published As

Publication number Publication date
US8058401B2 (en) 2011-11-15
US8470343B2 (en) 2013-06-25
US7575755B1 (en) 2009-08-18
EP1113815B1 (de) 2007-09-05
US20120034241A1 (en) 2012-02-09
EP1113815A1 (de) 2001-07-11
AUPP589398A0 (en) 1998-10-08
WO2000015254A1 (en) 2000-03-23
EP1113815A4 (de) 2002-11-06
US20090275737A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
DE69918233D1 (de) Polymilchsäure zusammensetzung und daraus hergestellter film
DE69933544D1 (de) Polymer und härtbare zusammensetzung
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
DE60025147D1 (de) Kosmetische Zusammensetzung und Verwendungen
NO20005913L (no) Legemiddelsammensetning
NO20022334L (no) Ny sammensetning og anvendelse
NO20004758L (no) Vaksinesammensetning
DE69923359D1 (de) Zusammensetzungen und daraus hergestellte gegenstände
ID26186A (id) Komposisi sampo
ID28694A (id) Komposisi sampo
DE69915066D1 (de) Biozide zusammensetzung und deren verwendung
ID29430A (id) Komposisi herbisida
PT1139761E (pt) Composicoes herbicidas e concentrados tensioactivos
DE69823804D1 (de) Azeotrope methoxyperfluorpropanzusammensetzungen und deren verwendung
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
IL148247A (en) Vaccine and its uses
DE60033043D1 (de) Modifizierte pflanzenviren und deren verwendungsmethoden
DE60022828D1 (de) Kosmetikeinheit und deren Zusammensetzung
DE69937060D1 (de) Immunogene zusammensetzungen und deren verwendungen
DE69724629D1 (de) Zusammensetzungen und deren verwendungen
DE69902473D1 (de) Kosmetikzusammensetzung
DE69919549D1 (de) Sauerstoffabsorbierende zusammensetzung und ihre anwendungsmethode
DE69724367D1 (de) Polyarylensulfid und zusammensetzung
DE60005514D1 (de) Dormanz-brechende zusammenstezung und deren verwendung

Legal Events

Date Code Title Description
8332 No legal effect for de